Last updated: March 23, 2020
COVID-19 Guidance for Proposals and Awards
Research Continuity & Planning for COVID-19
UC Santa Barbara and Santa Barbara County
Office of Research
- Support for GSRs and Postdocs - message from VCR Incandela - March 23, 2020
- The impact on fieldwork during the UCSB research shutdown - March 20, 2020
- UCSB Shutdown of All On-Campus Research - message from VCR Incandela - March 18, 2020
- UCSB Ramping Down On-Campus Research - message from VCR Incandela - March 16, 2020
- UCSB Research Continuity for COVID-19 - Message from VCR Incandela, March 10, 2020
- Guidance on in person human subjects research and the COVID-19 outbreak - Message from Director of Research Integrity Barry Rowan - March 13, 2020
- COVID-19 UCSB Lab Rampdown Safety Checklist
- Research Continuity Self Assessment
- UCSB Research Continuity Planning Abbreviated Worksheet
UC Santa Barbara
- Best Practices: Nanofab Coronavirus response
- COVID-19 Information for the UCSB Natural Reserve System
- COVID-19 Information for the UC Santa Barbara Campus
UCOP
- Research Grants Program Office: An Important Message to Our Colleagues Regarding the COVID-19 Pandemic
- Research Policy Analysis and Coordination COVID-19 updates
- Legislative Summary of COVID-19 Response, 3/17/20
Santa Barbara County
Agency Notices
- Impact on Existing Deadlines
- Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees, 3/16/20
- Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19), 3/4/20
- Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19), 3/5/20
- COVID-19 Flexibilities for Applicants and Recipients FAQs
- Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19, 3/16/20
- Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19, 3/12/20
- General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19, 3/10/20
- LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19), 3/9/20
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV), 2/6/20
- NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak
US Department of Agriculture (USDA)
- DOE Resources Supporting Coronavirus Research
- DOE Office of Science Accommodating Interruptions due to COVID-19
- Coronavirus Disease 2019 (COVID-19) Dear Colleague Letter - Asking for input on COVID-19 rapid research response involving DOE user facilities and infrastructure.
- DOE podcast interview with Office of Science Director Chris Fall regarding coordinating efforts across the Department and its 17 National Labs.
Department of Defense (DOD)
- DARPA - Frequently Asked Questions (FAQs) about COVID-19 (Coronavirus) for DARPA Performers
- United States Army Medical Research Acquisition Activity (USAMRAA) FAQs, 3/16/20
Department of Health and Human Services (DHHS)
- Virtual Town Hall 2020
- NASA - Assistant Administrator for Procurement Message on Coronavirus, 3/10/20
- Deadline for NASA Early Career Faculty (80HQTR20NOA01-20ECF_B1) Extended to April 22, 2020
National Endowment for the Arts
- Message from National Endowment for Arts Chairman Mary Anne Carter on COVID-19, 3/13/20
- National Endowment for the Arts FAQs and Information for Applicants and Grantees in response to COVID-19
National Endowment for the Humanities
Other
Department of Education (ED)
- Guidance for interruptions of study related to Coronavirus (COVID-19), 3/5/20
- Student and Exchange Visitor Program – Coronavirus Disease 2019 (COVID-19) and Potential Procedural Adaptations for F and M nonimmigrant students
Food and Drug Administration (FDA)
- FDA Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
- FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
Office of Management and Budget (OMB)
- M-20-11 Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19), 3/9/20
- M-20-17 Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations, 3/19/20
Council on Governmental Relations (COGR)